Funding for this research was provided by:
VetenskapsrĂĄdet
Sahlgrenska University Hospitals Research Foundations (970515)
University of Gothenburg
Article History
Received: 15 January 2024
Accepted: 15 March 2024
First Online: 23 March 2024
Declarations
:
: Prof. Lorentzon has received lecture fees from Amgen, Astellas, GE-Lunar, Lilly, Meda/Mylan, Parexel International, and UCB Pharma, outside the present work. Mr. Litsne has no conflicts of interest to report. Dr. Axelsson has received lecture fees from Amgen, Mylan/Meda, and Lilly, all outside the present work.